CalciMedica (CALC) Director Guerard Frederic Receives 10,000-Share Award

What Happened
Guerard Frederic, a director of CalciMedica, was granted a derivative award covering 10,000 shares on 2026-08-19. The filing reports an acquisition at $0.00 (no cash paid at grant); the instrument is reported as a derivative (option/award) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-19; filing date: 2026-08-21 (Accession 0001825009-26-000002).
• Reported terms: 10,000 shares; price at grant shown as $0.00; reported value $0.
• Vesting note (F1): 1/12th of the shares subject to the option vest in equal monthly installments over one year after the grant; fully vested by the 2027 annual meeting of stockholders.
• Shares owned after transaction: not specified in the filing.
• No late-filing flag noted in the document.

Context
This was a grant/award (derivative option) to a director — not a sale. Derivative awards give the holder the right to acquire shares subject to vesting and any exercise terms; this filing records the grant and its vesting schedule, not an immediate stock sale or cash exercise. Such grants are common as compensation for board service and do not by themselves indicate a buy/sell signal.